• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?

作者信息

Park Yong Eun

机构信息

Division of Gastroenterology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

出版信息

Intest Res. 2022 Apr;20(2):157-158. doi: 10.5217/ir.2022.00041. Epub 2022 Apr 29.

DOI:10.5217/ir.2022.00041
PMID:35508951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9081988/
Abstract
摘要

相似文献

1
Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?原发性硬化性胆管炎合并炎症性肠病在东方和西方患者中是否存在差异？
Intest Res. 2022 Apr;20(2):157-158. doi: 10.5217/ir.2022.00041. Epub 2022 Apr 29.
2
Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎患者肝移植的结果
Dis Colon Rectum. 2003 Aug;46(8):1124-8. doi: 10.1007/s10350-004-7291-9.
3
Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel disease.原发性硬化性胆管炎和炎症性肠病患者外周血淋巴细胞中的端粒功能障碍。
Dig Liver Dis. 2015 Sep;47(9):790-6. doi: 10.1016/j.dld.2015.05.002. Epub 2015 May 13.
4
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.炎症性肠病和原发性硬化性胆管炎患者抗中性粒细胞抗体的临床意义
Gut. 1992 May;33(5):657-62. doi: 10.1136/gut.33.5.657.
5
Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.与炎症性肠病相关的原发性硬化性胆管炎与无炎症性肠病时发生的原发性硬化性胆管炎有差异吗？一项针对66名受试者的研究。
Hepatology. 1990 Jan;11(1):7-11. doi: 10.1002/hep.1840110103.
6
Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.自身免疫性肝病和炎症性肠病中的抗中性粒细胞胞浆自身抗体
Liver. 1996 Feb;16(1):28-34. doi: 10.1111/j.1600-0676.1996.tb00700.x.
7
Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?原发性硬化性胆管炎的炎症性肠病：一种独特的疾病实体？
World J Gastroenterol. 2014 Mar 28;20(12):3245-54. doi: 10.3748/wjg.v20.i12.3245.
8
Serum autoantibodies in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者的血清自身抗体
J Hepatol. 2000 Feb;32(2):182-7. doi: 10.1016/s0168-8278(00)80061-6.
9
Sclerosing cholangitis.硬化性胆管炎
Curr Opin Gastroenterol. 2006 May;22(3):288-93. doi: 10.1097/01.mog.0000218966.78558.67.
10
The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.2018年加拿大炎症性肠病的影响：炎症性肠病的肠外疾病
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.

引用本文的文献

1
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD)：一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.

本文引用的文献

1
Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease.台湾炎症性肠病患者中年轻年龄及男性性别与原发性硬化性胆管炎的关联。
Intest Res. 2022 Apr;20(2):224-230. doi: 10.5217/ir.2021.00042. Epub 2022 Feb 8.
2
Landscape of inflammatory bowel disease in Singapore.新加坡炎症性肠病的概况
Intest Res. 2022 Jul;20(3):291-296. doi: 10.5217/ir.2021.00089. Epub 2022 Jan 7.
3
Natural history of inflammatory bowel disease: a comparison between the East and the West.炎症性肠病的自然史：东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.
4
Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.原发性硬化性胆管炎患者与炎症性肠病和健康对照者的肠道微生物组特征比较。
Mol Biol Rep. 2021 Jul;48(7):5519-5529. doi: 10.1007/s11033-021-06567-8. Epub 2021 Jul 25.
5
Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis.原发性硬化性胆管炎的全球发病率、患病率及特征：系统评价和荟萃分析。
Liver Int. 2021 Oct;41(10):2418-2426. doi: 10.1111/liv.15007. Epub 2021 Jul 19.
6
Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases.炎症性肠病肠外表现的发病机制与临床展望
Intest Res. 2020 Jul;18(3):249-264. doi: 10.5217/ir.2019.00128. Epub 2020 Apr 18.
7
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.Vedolizumab 治疗对炎症性肠病合并原发性硬化性胆管炎患者无效：GETAID 多中心队列研究。
J Crohns Colitis. 2019 Sep 27;13(10):1239-1247. doi: 10.1093/ecco-jcc/jjz088.
8
The IBD and PSC Phenotypes of PSC-IBD.原发性硬化性胆管炎-炎症性肠病的炎症性肠病和原发性硬化性胆管炎表型
Curr Gastroenterol Rep. 2018 Mar 28;20(4):16. doi: 10.1007/s11894-018-0620-2.
9
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.原发性硬化性胆管炎中独特的炎症性肠病表型。
World J Gastroenterol. 2015 Feb 14;21(6):1956-71. doi: 10.3748/wjg.v21.i6.1956.
10
Primary sclerosing cholangitis.原发性硬化性胆管炎。
Lancet. 2013 Nov 9;382(9904):1587-99. doi: 10.1016/S0140-6736(13)60096-3. Epub 2013 Jun 28.